{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:16:06Z","timestamp":1778220966406,"version":"3.51.4"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["14158"],"award-info":[{"award-number":["14158"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["15918"],"award-info":[{"award-number":["15918"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00415","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T04:53:15Z","timestamp":1589518395000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Epidemiology of Pediatric NMOSD in Germany and Austria"],"prefix":"10.3389","volume":"11","author":[{"given":"Christian","family":"Lechner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Breu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Maria","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kornek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Schanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Rost\u00e1sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"B1","first-page":"434","volume-title":"My\u00e9lite Aigu\u00eb Dorso-Lombaire Avec N\u00e9vrite Optique. Autopsie. Congres Fran\u00e7ais de M\u00e9decine","author":"Devic","year":"1895"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-10-8","article-title":"The history of neuromyelitis optica","volume":"10","author":"Jarius","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/s0140-6736(04)17551-x","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"B5","first-page":"42","article-title":"Neuromyelitis optica","volume":"13","author":"Wingerchuk","year":"2006","journal-title":"Int MS J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/1352458512451659","article-title":"Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies","volume":"19","author":"Chang","year":"2013","journal-title":"Mult Scler"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/archneur.64.6.901","article-title":"Neuromyelitis optica is a variant of multiple sclerosis","volume":"64","author":"Galetta","year":"2007","journal-title":"Arch Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/archneur.64.6.899","article-title":"Neuromyelitis optica is distinct from multiple sclerosis","volume":"64","author":"Weinshenker","year":"2007","journal-title":"Arch Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11940-008-0007-z","article-title":"Neuromyelitis optica","volume":"10","author":"Wingerchuk","year":"2008","journal-title":"Curr Treat Options Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/cen3.12107","article-title":"Evaluation of aquaporin-4 antibody assays","volume":"5","author":"Waters","year":"2014","journal-title":"Clin Exp Neuroimmunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/wnl.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","article-title":"Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica","volume":"87","author":"Waters","year":"2016","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","article-title":"NMO-IgG in the diagnosis of neuromyelitis optica","volume":"68","author":"Jarius","year":"2007","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen","volume":"291","author":"Jarius","year":"2010","journal-title":"J Neurol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/1352458516663853","article-title":"The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates","volume":"23","author":"Hamid","year":"2017","journal-title":"Mult Scler"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1352458517735191","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates","volume":"1","author":"Sepulveda","year":"2017","journal-title":"Mult Scler"},{"key":"B19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J Neuroinflamm"},{"key":"B20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/wnl.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","article-title":"Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype","volume":"12","author":"Probstel","year":"2015","journal-title":"J Neuroinflammation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp-2015-311743","article-title":"Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease","volume":"87","author":"Lechner","year":"2016","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1212\/nxi.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflamm."},{"key":"B26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflamm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/wnl.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11940-019-0541-x","article-title":"Treatment approaches for MOG-Ab-associated demyelination in children","volume":"21","author":"Hacohen","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2013.07.003","article-title":"Neuromyelitis optica with onset in childhood and adolescence","volume":"50","author":"Fragoso","year":"2014","journal-title":"Pediatr Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/jnnp-2014-308550","article-title":"Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features","volume":"86","author":"Absoud","year":"2015","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1212\/wnl.0000000000002283","article-title":"Clinical features of neuromyelitis optica in children: US network of pediatric MS Centers report","volume":"86","author":"Chitnis","year":"2016","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11940-018-0502-9","article-title":"Pediatric Neuromyelitis Optica Spectrum Disorders","volume":"20","author":"Gombolay","year":"2018","journal-title":"Curr Treat Options Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jns.2012.08.032","article-title":"Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan","volume":"323","author":"Houzen","year":"2012","journal-title":"J Neurol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1007\/s00415-013-6926-y","article-title":"The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom","volume":"260","author":"Jacob","year":"2013","journal-title":"J Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1177\/1352458514537699","article-title":"An epidemiological study of neuromyelitis optica in Isfahan","volume":"20","author":"Etemadifar","year":"2014","journal-title":"Mult Scler"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1177\/1352458514521503","article-title":"Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India","volume":"20","author":"Pandit","year":"2014","journal-title":"Mult Scler"},{"key":"B37","doi-asserted-by":"publisher","first-page":"174720","DOI":"10.1155\/2015\/174720","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult Scler Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2055217317730098","DOI":"10.1177\/2055217317730098","article-title":"Epidemiology of neuromyelitis optica in Latin America","volume":"3","author":"Alvarenga","year":"2017","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B39","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","article-title":"Incidence and prevalence of NMOSD in Australia and New Zealand","volume":"88","author":"Bukhari","year":"2017","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1212\/wnl.0000000000002655","article-title":"Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder","volume":"86","author":"Hyun","year":"2016","journal-title":"Neurology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.0b013e31822facdd","article-title":"Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children","volume":"77","author":"Langer-Gould","year":"2011","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2147\/clep.S156997","article-title":"Pediatric acquired demyelinating syndromes: a nationwide validation study of the Danish national patient register","volume":"10","author":"Boesen","year":"2018","journal-title":"Clin Epidemiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/0883073819895191","article-title":"Neuromyelitis optica spectrum disorder and anti-aquaporin 4 channel immunoglobulin in an australian pediatric demyelination cohort","volume":"35","author":"Dahan","year":"2020","journal-title":"J Child Neurol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.msard.2019.06.002","article-title":"Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 20082018: A nationwide, population-based cohort study","volume":"33","author":"Boesen","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the neuromyelitis optica study group","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e10455","DOI":"10.1371\/journal.pone.0010455","article-title":"Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica","volume":"5","author":"Mader","year":"2010","journal-title":"PLoS ONE"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/nxi.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1177\/1352458512470310","article-title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica","volume":"19","author":"Rostasy","year":"2013","journal-title":"Mult Scler"},{"key":"B50","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"Hoftberger","year":"2015","journal-title":"Mult Scler"},{"key":"B51","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fneur.2018.00888","article-title":"Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis","volume":"9","author":"Borisow","year":"2018","journal-title":"Front Neurol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.3389\/fimmu.2018.02753","article-title":"Myelin Oligodendrocyte glycoprotein antibody-associated disorders: toward a new spectrum of inflammatory demyelinating CNS disorders?","volume":"9","author":"Di Pauli","year":"2018","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0037-1604404","article-title":"MOG Spectrum disorders and role of MOG-antibodies in clinical practice","volume":"49","author":"Hennes","year":"2018","journal-title":"Neuropediatrics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neurol.2018.01.378","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder","volume":"174","author":"Ungureanu","year":"2018","journal-title":"Rev Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/wco.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/practneurol-2017-001787","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations","volume":"19","author":"Jurynczyk","year":"2019","journal-title":"Pract Neurol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1039","DOI":"10.1542\/peds.2007-2758","article-title":"Spectrum of pediatric neuromyelitis optica","volume":"122","author":"Lotze","year":"2008","journal-title":"Pediatrics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1212\/WNL.0b013e3181fc2823","article-title":"Neuromyelitis optica and NMO-IgG in European pediatric patients","volume":"75","author":"Huppke","year":"2010","journal-title":"Neurology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaneurol.2019.3656","article-title":"Coexistence of myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies in adult and pediatric patients","volume":"77","author":"Kunchok","year":"2019","journal-title":"JAMA Neurol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/dmcn.13703","article-title":"Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes","volume":"60","author":"Duignan","year":"2018","journal-title":"Dev Med Child Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00415\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T04:53:18Z","timestamp":1589518398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00415\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":61,"alternative-id":["10.3389\/fneur.2020.00415"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00415","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]},"article-number":"415"}}